知镜 Cognispect · 医学文献与研究工作台

Association between respiratory exacerbations and accelerated lung function decline in chronic obstructive pulmonary disease: a prospective observational population-based cohort study.

Zhou K, Wu F, Wan Q, Tang G, Deng Z, Dai C, Lu L, Huang S, Wu X, Wang X, Lin J, Wu F, Cai G, Li S, Xu B, Zeng X, Yang C, Chen S, Huang Y, Yu S, Zhou Y, Ran P.
Respiratory medicine · 2026-08-20 · PMID 42624223

文献摘要

Background Moderate-to-severe and severe respiratory exacerbations in chronic obstructive pulmonary disease (COPD) accelerate lung function decline. However, whether any mild-to-severe exacerbations are associated with lung function decline in COPD remains unclear, especially in mild-to-moderate COPD and in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) A. Methods The Early COPD (ECOPD) study was a 3-year, prospective cohort study conducted in China. Participants were diagnosed with COPD at baseline and had complete annual spirometry and exacerbation data from baseline to 3 years. Mild exacerbation was defined as an event treated domestically; moderate, treated as an outpatient; and severe, hospitalisation treatment. GOLD 2025 A was defined as COPD with few symptoms and without frequent exacerbations. Subgroup analyses were conducted in mild-to-moderate COPD and GOLD 2025 A. Results Of 915 participants with COPD at baseline in the ECOPD study, 703 (77%) had complete spirometry and exacerbation data each year during the 3-year follow-up and were included in the analysis. In COPD, patients with any mild-to-severe exacerbation had faster postbronchodilator forced expiratory volume in 1 s (FEV 1 ) decline (adjusted difference 13 mL/year, 95% confidence interval [CI] 3-23, P = 0.015) and faster postbronchodilator FEV 1 % predicted decline (adjusted difference 0.5%/year, 95% CI 0.1-0.9, P = 0.012) than those without. Results were generally consistent in direction in mild-to-moderate COPD and GOLD 2025 A. Conclusions Any mild-to-severe exacerbation was associated with accelerated lung function decline in COPD, even in mild-to-moderate COPD, and this finding was generally consistent with those with GOLD 2025 A. Any exacerbation in COPD should be considered in further disease management.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。